Motor Neurone Disease Trial, Recruiting NCT07302321 Sponsor: Istituto Auxologico Italiano Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07302321
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people living with ALS:

  • A person must have been diagnosed with ALS that is linked to a specific genetic change called C9orf72
  • A person must be 18 years of age or older
  • A person must be fluent in the Italian language
  • A person must be able to understand what the study involves and answer the questions in an online survey
  • A person must have signed a form giving their informed consent to take part

For caregivers:

  • A person must be a caregiver of an ALS patient with the C9orf72 genetic change who is also taking part in this study
  • A person must be 18 years of age or older
  • A person must have no significant difficulties with thinking or memory
  • A person must have signed a form giving their informed consent to take part

Who may not be able to join:

For people living with ALS:

  • People who have a significant level of cognitive difficulty (problems with thinking, memory, or understanding)
  • People who are unable to answer at least half of the questions in the online survey
  • People who score 11 or higher on a standard anxiety and depression questionnaire called the HADS (confirm with trial site)

For caregivers:

  • No specific exclusion criteria were listed beyond not meeting the inclusion criteria above (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +3902619111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Auxologico Italiano
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
31 March 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Multidisciplinary care; Home care; Satisfaction of primary needs; Satisfaction of economic support; Age; Burdensome commitment; Psychological support

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov